Capital Advisors »

Design Therapeutics shares owned by Capital Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 12 0.00
2024-06-30 $0 12 0.00
2024-03-31 $0 12 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr Core Div Grwth (DGRO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Capital Advisors

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
BlackRock
BlackRock
Frazier Life Sciences Management
Baker Bros. Advisors
Point72 Asset Management
Tang Capital Management
Almitas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
Goldman Sachs Group
Acadian Asset Management
D. E. Shaw & Co

View all funds holding Design Therapeutics